We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Saliva Test to Enable Early Detection of Diabetes and Obesity

By LabMedica International staff writers
Posted on 04 Aug 2025

Type 2 diabetes affects about 400 million people globally and is typically diagnosed through elevated blood glucose levels. More...

However, conditions like insulin resistance and hyperinsulinemia may begin developing 10 to 20 years before a diagnosis. Detecting hyperinsulinemia early is important because it is a known predictor of several chronic conditions, including Type 2 diabetes, hypertension, cardiovascular disease, stroke, cancer, and obesity. Current methods to detect insulin levels require invasive blood sampling and lab-based analysis, making early detection less accessible. Now, a new study reveals that a saliva-based test may offer a simple, non-invasive method to identify people at risk of developing metabolic disorders, even before symptoms appear or blood sugar levels begin to rise.

The study, by researchers at the UBC Okanagan’s School of Health and Exercise Sciences (Kelowna, BC, Canada), evaluated whether insulin levels in saliva could serve as a reliable indicator of metabolic health. The research included 94 healthy participants across a range of body sizes who, after a fasting period, consumed a standardized meal-replacement shake. Saliva samples were collected at 30, 60, and 90 minutes post-consumption, alongside finger-prick blood glucose tests. Prior studies at UBCO had already shown that saliva insulin levels closely track plasma insulin levels throughout the day, even after meals with differing carbohydrate contents. This new study aimed to build on that insight and develop a practical, needle-free test for early detection of hyperinsulinemia.

The findings, published in Applied Physiology, Nutrition, and Metabolism, indicate that saliva insulin levels were significantly higher in individuals with obesity, even when their blood glucose levels remained normal. The study also discovered that some lean individuals exhibited large saliva insulin spikes after the test meal, suggesting elevated risk despite healthy weight and glucose levels. Additionally, waist circumference showed a stronger correlation with elevated saliva insulin than age or overall body weight, indicating it may be a better predictor of early metabolic dysfunction. Researchers suggest that saliva testing could become a valuable tool to distinguish between metabolically healthy individuals and those at risk, and future work will focus on refining this method for broader clinical application.

"If hyperinsulinemia can be detected before blood glucose levels start to rise, people at risk for Type 2 diabetes could be identified early, allowing for lifestyle changes and other treatments to be introduced long before glucose levels rise," said Dr. Jonathan Little, lead investigator of the study.

Related Links:
UBCO School of Health and Exercise Sciences


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.